{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T02:28:55Z","timestamp":1648952935325},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,4,1]]},"DOI":"10.1093\/europace\/eum011","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T04:01:00Z","timestamp":1172808060000},"page":"239-245","source":"Crossref","is-referenced-by-count":2,"title":["Outcome of pharmacological rhythm control for new-onset persistent atrial fibrillation in patients with systolic heart failure: a comparison with patients with normal left ventricular function"],"prefix":"10.1093","volume":"9","author":[{"given":"Martin E.W.","family":"Hemels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ans C.P.","family":"Wiesfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"Van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten P.","family":"Van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle C.","family":"Van Gelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,3,1]]},"reference":[{"key":"key\n\t\t\t\t20171012132033_EUM011C1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1540-8167.2002.00399.x","article-title":"Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets","volume":"13","author":"Ehrlich","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C2","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/01.CIR.0000090688.49283.67","article-title":"Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans","volume":"108","author":"Sanders","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0002-8703(89)90223-8","article-title":"The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillation","volume":"118","author":"Atwood","year":"1989","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171012132033_EUM011C5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9149(93)90352-D","article-title":"Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease","volume":"72","author":"Van Gelder","year":"1993","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.CIR.84.1.40","article-title":"Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients","volume":"84","author":"Middlekauff","year":"1991","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C7","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C8","first-page":"VI102","article-title":"The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group","volume":"87","author":"Carson","year":"1993","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation\u2014Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial","volume":"356","author":"Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171012132033_EUM011C10","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012132033_EUM011C11","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012132033_EUM011C12","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study","volume":"41","author":"Carlsson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0002-8703(02)00129-1","article-title":"Rationale:design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation:Congestive Heart Failure (AF-CHF) trial","volume":"144","year":"2002","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171012132033_EUM011C14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0735-1097(92)90003-6","article-title":"Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators","volume":"20","author":"Flaker","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/hrt.82.4.486","article-title":"Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation","volume":"82","author":"Tuinenburg","year":"1999","journal-title":"Heart"},{"key":"key\n\t\t\t\t20171012132033_EUM011C16","first-page":"1276","article-title":"Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis","volume":"44","author":"Kaufman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C17","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199909163411209","article-title":"Atrial fibrillation in heart failure","volume":"341","author":"Stevenson","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012132033_EUM011C18","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/archinte.1996.00440210109011","article-title":"Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation","volume":"156","author":"Van Gelder","year":"1996","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171012132033_EUM011C19","doi-asserted-by":"crossref","first-page":"24A","DOI":"10.1016\/S0002-9149(97)89115-1","article-title":"Atrial fibrillation: maintenance of sinus rhythm versus rate control","volume":"77","author":"Sopher","year":"1996","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C20","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMe020137","article-title":"Management of atrial fibrillation\u2014radical reform or modest modification?","volume":"347","author":"Falk","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171012132033_EUM011C21","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","article-title":"Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators","volume":"98","author":"Deedwania","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1378\/chest.120.1.132","article-title":"In patients with chronic atrial fibrillation and left ventricular systolic dysfunction, restoration of sinus rhythm confers substantial benefit","volume":"120","author":"Azpitarte","year":"2001","journal-title":"Chest"},{"key":"key\n\t\t\t\t20171012132033_EUM011C23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1536\/jhj.45.591","article-title":"Comparison of rate and rhythm control in patients with atrial fibrillation and nonischemic heart failure","volume":"45","author":"Okcun","year":"2004","journal-title":"Jpn Heart J"},{"key":"key\n\t\t\t\t20171012132033_EUM011C24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurheartj\/ehi637","article-title":"Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study","volume":"27","author":"Rienstra","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20171012132033_EUM011C25","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0735-1097(03)00577-1","article-title":"Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study","volume":"42","author":"Pappone","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C27","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1161\/01.CIR.101.22.2631","article-title":"Effects of experimental heart failure on atrial cellular and ionic electrophysiology","volume":"101","author":"Li","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/hc0202.102014","article-title":"Consequences of atrial tachycardia-induced remodeling depend on the preexisting atrial substrate","volume":"105","author":"Shinagawa","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C29","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/01.CIR.0000142052.03565.87","article-title":"Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure","volume":"110","author":"Cha","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C30","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.92.7.1954","article-title":"Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats","volume":"92","author":"Wijffels","year":"1995","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C31","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1161\/01.CIR.96.9.3157","article-title":"Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat","volume":"96","author":"Ausma","year":"1997","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10840-005-2362-y","article-title":"Atrial fibrillation: basic mechanisms, remodeling and triggers","volume":"13","author":"Shiroshita-Takeshita","year":"2005","journal-title":"J Interv Card Electrophysiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C33","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/hc4601.099402","article-title":"Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cardiores.2003.08.014","article-title":"Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways","volume":"60","author":"Cardin","year":"2003","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20171012132033_EUM011C35","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0735-1097(03)00464-9","article-title":"Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation","volume":"41","author":"Kumagai","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1071-9164(05)80004-1","article-title":"Effects of lisinopril in patients with heart failure and chronic atrial fibrillation","volume":"1","author":"Van den Berg","year":"1995","journal-title":"J Card Fail"},{"key":"key\n\t\t\t\t20171012132033_EUM011C37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.CIR.0000022665.18619.83","article-title":"Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study","volume":"106","author":"Madrid","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C38","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1161\/01.CIR.0000072793.81076.D4","article-title":"Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies of Left Ventricular Dysfunction (SOLVD) trials","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012132033_EUM011C39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2004.03.056","article-title":"Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation","volume":"44","author":"L'Allier","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention for end Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012132033_EUM011C41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2004.09.033","article-title":"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)","volume":"149","author":"Maggioni","year":"2005","journal-title":"Am Heart J"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/9\/4\/239\/1797581\/eum011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T17:37:20Z","timestamp":1507829840000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/europace\/article\/9\/4\/239\/640979\/Outcome-of-pharmacological-rhythm-control-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2007,3,1]]},"published-print":{"date-parts":[[2007,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eum011","relation":{},"ISSN":["1532-2092","1099-5129"],"issn-type":[{"value":"1532-2092","type":"electronic"},{"value":"1099-5129","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,4]]},"published":{"date-parts":[[2007,3,1]]}}}